2020
DOI: 10.1016/j.annemergmed.2020.06.047
|View full text |Cite
|
Sign up to set email alerts
|

Diagnostic Reclassification by a High-Sensitivity Cardiac Troponin Assay

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 54 publications
0
8
0
Order By: Relevance
“…Clinicians may be subject to medical malpractice suits for missed or delayed diagnoses of AMI as AMI is one of the most common diagnoses in lawsuits against EM physicians 8 . Professional societies such as the American Heart Association (AHA) and European Society of Cardiology (ESC) currently differ in their guidelines for the use of a single troponin, with the AHA recommending serial troponins and the ESC providing an option for a single troponin to exclude AMI, 15,43,44 and physicians are using single conventional and high‐sensitivity cardiac troponin testing in clinical practice 45,46 …”
Section: Questionmentioning
confidence: 99%
See 1 more Smart Citation
“…Clinicians may be subject to medical malpractice suits for missed or delayed diagnoses of AMI as AMI is one of the most common diagnoses in lawsuits against EM physicians 8 . Professional societies such as the American Heart Association (AHA) and European Society of Cardiology (ESC) currently differ in their guidelines for the use of a single troponin, with the AHA recommending serial troponins and the ESC providing an option for a single troponin to exclude AMI, 15,43,44 and physicians are using single conventional and high‐sensitivity cardiac troponin testing in clinical practice 45,46 …”
Section: Questionmentioning
confidence: 99%
“…high-sensitivity cardiac troponin testing in clinical practice. 45,46 These differences in guidelines likely reflect differences in the adoption of high-sensitivity troponin assays, which have been used internationally for nearly a decade but only approved for use in the United States in 2017. Despite the increased incorporation of high-sensitivity troponin into accelerated diagnostic protocols, the authors acknowledge that many EDs may currently only have access to conventional troponin at this time.…”
Section: Decision Criteria and Additional Considerationsmentioning
confidence: 99%
“…Moreover, this limitation led to the selection of a population at higher CV risk and for whom a troponin dosage was considered necessary by the treating physician. Secondly, our series was based on conventional troponin I dosage, leading to a possible underestimation of myocardial injury compared with other studies using high-sensitivity cardiac troponin T [ 11 , 18 , 44 ]. The most recent guidelines do indeed recommend the preferential use of high-sensitivity methods [ 16 , 45 , 46 ].…”
Section: Discussionmentioning
confidence: 99%
“…Although 7% more of these patients underwent angiography, MI and cardiovascular death remained unchanged, introducing some concern for overdiagnosis leading to increased unnecessary testing and potential for iatrogenic complications 8 . Similarly, a prospective observational study in the United States found that when hs‐cTnT assay was used, 16% of patients were classified as myocardial injury 9 . These studies demonstrate that, compared with conventional troponin assays, a significantly higher proportion of patients undergoing testing with hs‐cTn assays will have elevated baseline troponin values, but this should not necessarily be mistaken for ACS.…”
Section: Interpretationsmentioning
confidence: 99%